SGCA, sarcoglycan alpha, 6442

N. diseases: 111; N. variants: 57
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030193
Disease: Pain
Pain
0.100 GeneticVariation phenotype BEFREE The RLPD-group scored significantly lower than the ACL-group for the three KOOS subscales "Pain" (73.6 vs. 79.8, p < 0.05), "Symptoms" (71.7 vs. 79.3, p < 0.05) and "ADL" (84.7 vs 89.5, p < 0.05). 31286929 2019
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE Nearly half (48%) of participants with urinary incontinence or falls, 61% with ADL disability, and 49% of those with frailty also had multisite pain. 30361952 2019
CUI: C0030193
Disease: Pain
Pain
0.100 GeneticVariation phenotype BEFREE We found no significant average treatment effect on the treated (ATT) of working to age 66 or above on the outcomes, measured an average of 12 years after retirement: mortality (ATT -0.039), the ability to climb stairs (ATT -0.023), self-rated health (ATT -0.009), ADL limitations (ATT -0.023), or musculoskeletal pain (ATT -0.009) in late life. 30849673 2019
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE VAS pain, FAAM-ADL, and pain satisfaction surveys were collected preoperatively and minimum 1-year postoperatively. 30841749 2019
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE Patients with neural compression scored significantly higher in the domain of pain and patients requiring assistive devices for ambulation scored significantly higher in the domains of ADL and social functions. 31421948 2019
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE The range in differences between the 2-year change in individual PROMs were as follows: HOOS pain (0.6-2.4), HOOS symptoms (0-3.8), HOOS ADL (0.4-4), and HOOS QOL (0.5-3.6). 31296068 2019
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE Interventions addressing physical functioning or fatigue and pain might contribute to enhancing ADL ability and HRQoL among people with advanced cancer. 30740805 2019
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE First, we applied a hierarchical cluster analysis and the principal component analysis (PCA) to a panel of questionnaires [comorbidity (Charlson, CIRS), clinical stability (MEWS), social frailty (Flugelman), cognitive dysfunction (SPSMQ), depression (5-item GDS), functional dependence (ADL, IADL, Barthel), risk of sore threats (Exton-Smith scale), nutrition (MNA), pain (NRPS), adherence to therapy (Morisky scale)], in order to select domains informative for the definition of complexity. 29659593 2018
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE Age, education, pain, falls, household not fully adapted for one's needs, using assistive devices, lack of satisfaction with life, and low assessment of quality of life had a significant impact on the prevalence of ADL and/or IADL disabilities in the elderly inhabitants of rural areas. 30260182 2018
CUI: C0030193
Disease: Pain
Pain
0.100 GeneticVariation phenotype BEFREE SHOMRI total scores correlated with intraoperative femoral cartilage grade (ρ = 0.42; p = 0.002), acetabular cartilage grade (ρ = 0.30; p = 0.046), and labral tear grade (ρ = 0.42; p = 0.003) as well as with preoperative Tönnis grade (ρ = 0.37, p = 0.013), HOOS pain score (ρ = -0.33; p = 0.039), HOOS ADL score (ρ = -0.39; p = 0.007), and HOOS sports score (ρ = -0.30; p = 0.037). 29947434 2018
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE In the total sample, 12 of the 20 independent variables were significantly associated with LS: need of help with ADL; walking difficulties; number of non-motor symptoms (NMS); fatigue; depressive symptoms; general self-efficacy; motor symptoms; pain; PD severity; freezing episodes; gender (woman); and fluctuations. 27726132 2017
CUI: C0030193
Disease: Pain
Pain
0.100 Biomarker phenotype BEFREE Secondary outcome measures were ADL-dependency and pain documentation. 28241785 2017